92
92
Oct 27, 2014
10/14
by
Yu, Ji Hee; Kim, Min-Seon
texts
eye 92
favorite 0
comment 0
This article is from Diabetes & Metabolism Journal , volume 36 . Abstract The prevalence of obesity has been rapidly increasing worldwide over the last several decades and has become a major health problem in developed countries. The brain, especially the hypothalamus, plays a key role in the control of food intake by sensing metabolic signals from peripheral organs and modulating feeding behaviors. To accomplish these important roles, the hypothalamus communicates with other brain areas...
Source: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530708
53
53
Oct 24, 2014
10/14
by
Park, Subin; Yi, Ki Kyoung; Kim, Min-Seon; Hong, Jin Pyo
texts
eye 53
favorite 0
comment 0
This article is from Behavioral and Brain Functions : BBF , volume 9 . Abstract Background: In contrast to olanzapine, ziprasidone has been reported to cause minimal or no weight gain. This study aimed to compare the effects of ziprasidone and olanzapine on weight, body composition, appetite, resting energy expenditure, substrate oxidation, and metabolic parameters in adults with schizophrenia or other psychotic disorders. Methods: Twenty adults with schizophrenia or other psychotic disorders...
Source: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729530
60
60
Oct 11, 2014
10/14
by
Won, Jong Chul; Park, Cheol-Young; Oh, Sang Woo; Lee, Eon Sook; Youn, Byung-Soo; Kim, Min-Seon
texts
eye 60
favorite 0
comment 0
This article is from PLoS ONE , volume 9 . Abstract Obesity and insulin resistance are hallmarks of the metabolic syndrome, which is associated with low-grade chronic inflammation. Clusterin/apolipoprotein J is an abundant plasma chaperone protein that has recently been suggested as a potential biomarker that reflects the inflammatory process in Alzheimer's disease. In the present study, we investigated anthropometric and clinical factors affecting the plasma levels of clusterin in healthy...
Source: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116172
48
48
Oct 27, 2014
10/14
by
Lee, Sang Ah; Jeong, Eunheiu; Kim, Eun Hee; Shin, Mi-Seon; Hwang, Jenie Yoonoo; Koh, Eun Hee; Lee, Woo Je; Park, Joong-Yeol; Kim, Min-Seon
texts
eye 48
favorite 0
comment 0
This article is from Diabetes & Metabolism Journal , volume 36 . Abstract Background: Fibroblast growth factor 21 (FGF21) was originally identified as a paroxysm proliferator activated receptor-α target gene product and is a hormone involved in metabolic regulation. The purpose of this study was to investigate the diurnal variation of serum FGF21 concentration in obese and non-obese healthy volunteers. Methods: Blood samples were collected from five non-obese (body mass index [BMI] ≤23...
Source: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283824
47
47
Oct 25, 2014
10/14
by
Yu, Ji Hee; Hwang, Jenie Yoonoo; Shin, Mi-Seon; Jung, Chang Hee; Kim, Eun Hee; Lee, Sang Ah; Koh, Eun Hee; Lee, Woo Je; Kim, Min-Seon; Park, Joong-Yeol; Lee, Ki-Up
texts
eye 47
favorite 0
comment 0
This article is from Diabetes & Metabolism Journal , volume 35 . Abstract Background: Peripheral arterial disease (PAD) is a common manifestation of systemic atherosclerosis and is associated with significant morbidity and mortality. Diabetes is known to increase the risk of PAD two- to four-fold. The prevalence of PAD in Korean diabetic patients has not been established. In this study, we investigated the prevalence of PAD in Korean patients with type 2 diabetes attending a large...
Source: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221031
